| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9275 | 
      | Human Intestinal Absorption | HIA+ | 0.9908 | 
      | Caco-2 Permeability | Caco2+ | 0.6203 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8692 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8880 | 
                                                     | Non-inhibitor | 0.9281 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8643 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.5854 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7791 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9090 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7382 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9368 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8639 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9661 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9481 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8112 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9434 | 
                                                                    | Non-inhibitor | 0.8515 | 
      | AMES Toxicity | Non AMES toxic | 0.9132 | 
      | Carcinogens | Non-carcinogens | 0.9182 | 
      | Fish Toxicity | Low FHMT | 0.8051 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.5137 | 
      | Honey Bee Toxicity | Low HBT | 0.8386 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | III | 0.8266 | 
      | Carcinogenicity (Three-class) | Non-required | 0.4729 |